Ashland Inc.

NYSE ASH

Ashland Inc. Shareholders' Equity for the quarter ending September 30, 2024: USD 2.87 B

Ashland Inc. Shareholders' Equity is USD 2.87 B for the quarter ending September 30, 2024, a -7.39% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Ashland Inc. Shareholders' Equity for the quarter ending September 30, 2023 was USD 3.10 B, a -3.82% change year over year.
  • Ashland Inc. Shareholders' Equity for the quarter ending September 30, 2022 was USD 3.22 B, a 17.01% change year over year.
  • Ashland Inc. Shareholders' Equity for the quarter ending September 30, 2021 was USD 2.75 B, a -9.35% change year over year.
  • Ashland Inc. Shareholders' Equity for the quarter ending September 30, 2020 was USD 3.04 B, a -14.98% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
NYSE: ASH

Ashland Inc.

CEO Mr. Guillermo Novo
IPO Date March 17, 1980
Location United States
Headquarters 8145 Blazer Drive
Employees 3,200
Sector Health Care
Industries
Description

Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. Ashland Inc. was founded in 1924 and is based in Wilmington, Delaware.

Similar companies

AVTR

Avantor, Inc.

USD 21.72

-1.36%

AXTA

Axalta Coating Systems Ltd.

USD 34.69

1.34%

BCPC

Balchem Corporation

USD 158.62

1.47%

KWR

Quaker Chemical Corporation

USD 132.16

2.36%

ESI

Element Solutions Inc

USD 24.88

-0.48%

SXT

Sensient Technologies Corporation

USD 69.55

1.92%

ODC

Oil-Dri Corporation of America

USD 41.80

1.70%

FUL

H.B. Fuller Company

USD 63.73

0.81%

MTX

Minerals Technologies Inc.

USD 75.62

2.83%

IOSP

Innospec Inc.

USD 111.44

3.26%

StockViz Staff

January 15, 2025

Any question? Send us an email